The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts
Open accessAbstract
Highlights • Review of the present status of the development of antimicrobial peptides (AMPs).• Recent advances in designing new anti-infective agents with enhanced activity.• Transient expression of AMPs in tobacco to boost the biosynthesis of pharmaceutics.• CRISPRs, an impressive genome editing tool to enhance the biosynthesis of new AMPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Mali, P., Aach, J., Stranges, P. B., Esvelt, K. M., Moosburner, M., Kosuri, S., Yang, L., & Church, G. M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2675 · Cited by 1,752 · cited 3×
“The Cas9 nuclease can be further engineered into a nickase, which only cleaves a single strand of DNA and the same strategy on the other strand enhances the specificity of site recognition and consistently minimizes off-target effects [67, [70] [71] [72] [73] .”
BackgroundFuture directions for peptide therapeutics development
Kaspar, A. A., & Reichert, J. M. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.011 · Cited by 750
Histatins: Antimicrobial peptides with therapeutic potential
Kavanagh, K., & Dowd, S. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022971 · Cited by 223
Cardiolipin Prevents Membrane Translocation and Permeabilization by Daptomycin
Zhang, T., Muraih, J. K., Tishbi, N., Herskowitz, J., Victor, R. L., Silverman, J., Uwumarenogie, S., Taylor, S. D., Palmer, M., & Mintzer, E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554444 · Cited by 162
Topical Antibacterial Treatments for Acne Vulgaris: Comparative Review and Guide to Selection
Tan, H.-H. (2004) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200405020-00002 · Cited by 61
Migliolo, L., Silva, O. N., Silva, P. A., Costa, M. P., Costa, C. R., Nolasco, D. O., Barbosa, J. A. R. G., Silva, M. R. R., Bemquerer, M. P., Lima, L. M. P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047047 · Cited by 48
Self-citation
Cited by
Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions
Mohammad, S., & Thiemermann, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594150 · Cited by 585
Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds
Erdem Büyükkiraz, M., & Kesmen, Z. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15314 · Cited by 454
Majeed, M., Majeed, S., Nagabhushanam, K., Mundkur, L., Rajalakshmi, H., Shah, K., & Beede, K. (2020) · Cosmetics · doi:10.3390/cosmetics7030070 · Cited by 68
Anaya, K., Podszun, M., Franco, O. L., de Almeida Gadelha, C. A., & Frank, J. (2020) · Plant Foods for Human Nutrition · doi:10.1007/s11130-020-00826-y · Cited by 24
Self-citation
Metadata
- Authors
- da Cunha, N. B., Cobacho, N. B., Viana, J. F. C., Lima, L. A., Sampaio, K. B. O., Dohms, S. S. M., Ferreira, A. C. R., de la Fuente-Núñez, C., Costa, F. F., Franco, O. L., & Dias, S. C.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 22
- Issue
- 2
- Pages
- 234-248
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2553758814
- Cited by
- 192
- References
- 7
- FWCI
- 12.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts. https://app.cochat.ai/papers/10.1016/j.drudis.2016.10.017
- The paper
- da Cunha, N. B., Cobacho, N. B., Viana, J. F. C., Lima, L. A., Sampaio, K. B. O., Dohms, S. S. M., Ferreira, A. C. R., de la Fuente-Núñez, C., Costa, F. F., Franco, O. L., & Dias, S. C. (2017). The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts. Drug Discovery Today. https://doi.org/10.1016/j.drudis.2016.10.017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
